ALEMBIC PHARMACEUTICALS LTD. - Statement Regarding Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Quarter Ended 30Th September, 2017

With reference to the captioned subject, we enclose herewith Statement regarding investor complaints as per Regulation 13(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the quarter ended 30th September, 2017.<BR> <BR> We request you to kindly take the same on record.